Detail page

Knowledge Web

Person

Natalie Frede

Wissenschaftlerin

Name	Natalie Frede
Place	Freiburg im Breisgau Deutschland
Profession	Wissenschaftlerin (characteristic profession)
Related	Centrum für Chronische Immundefizienz Medizin (Studienfach)
Record type	Person
GND-Identifier	112597124X
Record ID	112597124X
Involved in show all Psoriasis and Psoriatic Arthritis Have a Major Impact on Quality of Life and Depressive Symptoms: A Cross-Sectional Study of 300 Patients Burden of disease and impact on quality of life in chronic back pain – a comparative cross-sectional study of 150 axial spondyloarthritis and 150 orthopedic back pain patients JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis Psoriasis and psoriatic arthritis have a major impact on quality of life and depressive symptoms : : a cross-sectional study of 300 patients Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms Confirmation of hyperimmunoglobulin E syndrome in two patients with an ocular problem: Detection of two new DOCK8 mutations Genetic analysis of a cohort of 275 patients with hyper-IgE syndromes and/or chronic mucocutaneous candidiasis Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2 Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibodydeficiencies? The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1 Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Natalie Frede

Psoriasis and Psoriatic Arthritis Have a Major Impact on Quality of Life and Depressive Symptoms: A Cross-Sectional Study of 300 Patients

Burden of disease and impact on quality of life in chronic back pain – a comparative cross-sectional study of 150 axial spondyloarthritis and 150 orthopedic back pain patients

JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis

Psoriasis and psoriatic arthritis have a major impact on quality of life and depressive symptoms : : a cross-sectional study of 300 patients

Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms

Confirmation of hyperimmunoglobulin E syndrome in two patients with an ocular problem: Detection of two new DOCK8 mutations

Genetic analysis of a cohort of 275 patients with hyper-IgE syndromes and/or chronic mucocutaneous candidiasis

Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis

Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis

Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2

Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibodydeficiencies?

The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1

Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease